We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology to Treat Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 10 Mar 2009
Alphatec Spine (Carlsbad, CA, USA), a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, has announced that it has entered into a license agreement with Helix Point (Shermans Dale, PA, USA) to develop and commercialize two interspinous devices to treat lumbar spinal stenosis (LSS). More...


The Helifix is a non-fusion interspinous device designed to provide relief from the symptoms of LSS by providing flexion in the posterior elements; the Helifuse is similar in design to Helifix, but will be a fusion device that may be combined with percutaneous spinal fixation. Both devices work by preventing extension at the spinal level of interest, thus reducing symptoms. The Helifix device is self-distracting and can be made from a variety of materials including titanium, polyaryletheretherketone (PEEK), or bone, and is designed so that it can be inserted and removed percutaneously. It can be inserted by spine surgeons and interventional radiologists, and the procedure can be performed on an inpatient or outpatient basis. Because of the design and the different materials that can be used, the device could be used for both fusion and nonfusion procedures.

"It is estimated that 37% of surgeries on patients age 65 or older are for spinal stenosis,” said Dirk Kuyper, president and CEO of Alphatec Spine. "Helifix and Helifuse will allow surgeons to treat the older patient with spinal stenosis in a minimally invasive manner. These products complement our growing portfolio of aging spine products.”

"Neural passageways are compromised by aging and exacerbated by extension in patients with spinal stenosis,” said James J. Yue, M.D., a member of Alphatec Spine's scientific advisory board and an associate professor at Yale University (New Haven, CT, USA). "Clinical observations of patients show they experience relief in their symptoms with flexion. So it stands to reason that by preventing extension at the level of interest, symptoms may be reduced or eliminated.”

LSS arises from age-related changes to the facets and the intervertebral disc that can eventually lead to a reduction in the patient's quality of life. More than two million people 65 years and older in the United States were diagnosed with spinal stenosis in 2008. There were more than 145,000 of these procedures performed on LSS patients aged 65 years and older in 2008, and it is estimated that this number will grow to over 160,000 procedures by the year 2012. Traditionally, lumbar spinal stenosis has been treated with a laminectomy.

Related Links:

Alphatec Spine
Helix Point



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Patient Monitoring System
AlarmSense
New
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The method uses data streams commonly available on consumer wearables, including heart rate, physical activity, and oxygen saturation (photo courtesy of 123RF)
Image: The method uses data streams commonly available on consumer wearables, including heart rate, physical activity, and oxygen saturation (photo courtesy of 123RF)

Wearable AI Tool Predicts Hospitalization Risk in Heart Failure

Heart failure, a condition in which the heart cannot pump enough blood to meet the body’s needs, is a leading driver of unplanned hospital use. Clinicians often lack continuous insight into symptom changes... Read more

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.